CTMX
CytomX Therapeutics Inc

4,467
Mkt Cap
$901.4M
Volume
3.67M
52W High
$6.35
52W Low
$0.40
PE Ratio
12.72
CTMX Fundamentals
Price
$5.32
Prev Close
$5.43
Open
$5.45
50D MA
$4.73
Beta
1.42
Avg. Volume
3.34M
EPS (Annual)
$0.3761
P/B
8.18
Rev/Employee
$1.14M
$3.95
Loading...
Loading...
News
all
press releases
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Recommendation of "Moderate Buy" by Brokerages
CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight analysts that are covering the firm, MarketBeat reports. One analyst...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
CytomX Therapeutics Conference: CFO Highlights Varseta-M CRC Response Data, Next Catalysts
CytomX Therapeutics (NASDAQ:CTMX) Chief Financial Officer Chris Ogden outlined the company's current priorities and upcoming catalysts during a fireside chat moderated by Guggenheim senior biotech...
MarketBeat·2d ago
News Placeholder
Qiagen (QGEN) Meets Q4 Earnings Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of +0.83% and +2.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year High - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Sets New 12-Month High - Here's What Happened...
MarketBeat·11d ago
News Placeholder
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?
Regenxbio (RGNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·15d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Should You Buy?
CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Here's Why...
MarketBeat·23d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Shares Down 5.3% - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 5.3% - Should You Sell...
MarketBeat·24d ago
News Placeholder
Guggenheim Upgrades CytomX Therapeutics (NASDAQ:CTMX) to "Strong-Buy"
Guggenheim upgraded shares of CytomX Therapeutics to a "strong-buy" rating in a research note on Tuesday...
MarketBeat·24d ago
News Placeholder
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Qiagen (QGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·24d ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Recommendation of "Moderate Buy" from Brokerages
CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been given an average rating of "Moderate Buy" by the seven brokerages that are presently covering the stock, Marketbeat.com reports. One...
MarketBeat·25d ago
<
1
2
...
>

Latest CTMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.